Suppr超能文献

使用研究人员问卷识别随机临床试验中患者招募的重要障碍。

Identifying important barriers to recruitment of patients in randomised clinical studies using a questionnaire for study personnel.

机构信息

Department of Clinical Neuroscience, Neurology, Karolinska Institutet, Nobels väg 6, SE-171 76, Stockholm, Sweden.

Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, SE-18288, Stockholm, Sweden.

出版信息

Trials. 2019 Oct 30;20(1):618. doi: 10.1186/s13063-019-3737-1.

Abstract

BACKGROUND

Many randomised controlled trials (RCT) fail to meet their recruitment goals. Study personnel play a key role in recruitment. The aim of this study was to identify successful strategies that study personnel consider to be important in patient recruitment to RCT.

METHODS

We constructed a questionnaire based on the literature, discussions with colleagues and our own experience as trialists. The survey was named "What is Important for Making a Study Successful questionnaire" (WIMSS-q). Our target group was the study personnel in the ongoing EFFECTS study. The questionnaire was sent out electronically to all physicians and nurses (n = 148). Success factors and barriers were divided according to patient, centre and study level, respectively.

RESULTS

Responses were received from 94% of the study personnel (139/148). The five most important factors at centre level for enhancing recruitment were that the research question was important (97%), a simple procedure for providing information and gaining consent (92%), a highly engaged local principal investigator and research nurse (both 87%), and that study-related follow-ups are practically feasible and possible to coordinate with the clinical follow-up (87%). The most significant barrier at the local centre was lack of time and resources devoted to research (72%). Important patient-related barriers were fear of side effects (35%) and language problems (30%).

CONCLUSIONS

For recruitment in an RCT to be successful, the research question must be relevant, and the protocol must be simple and easy to implement in the daily routine.

TRIAL REGISTRATION

The protocol for this study was registered at the Northern Ireland Hub for trials methodology research (SWAT ID 64 ). The EFFECTS study has EudraCT number 2011-006130-16 and was registered 17 February 2016 at ClinicalTrials.gov number NCT02683213 .

摘要

背景

许多随机对照试验(RCT)未能达到其招募目标。研究人员在招募中起着关键作用。本研究旨在确定研究人员认为对 RCT 患者招募重要的成功策略。

方法

我们根据文献、与同事的讨论以及我们作为试验者的经验,构建了一份问卷。该调查名为“使研究成功的重要因素问卷”(WIMSS-q)。我们的目标人群是正在进行的 EFFECTS 研究中的研究人员。问卷以电子方式发送给所有医生和护士(n=148)。成功因素和障碍分别根据患者、中心和研究水平进行了划分。

结果

收到了 94%(139/148)的研究人员的回复。增强招募的中心层面的五个最重要因素是研究问题重要(97%)、提供信息和获得同意的程序简单(92%)、高度参与的本地首席研究员和研究护士(均为 87%),以及与研究相关的随访在实践上可行且与临床随访相协调(87%)。当地中心最大的障碍是用于研究的时间和资源不足(72%)。重要的患者相关障碍是对副作用的恐惧(35%)和语言问题(30%)。

结论

为了 RCT 的招募成功,研究问题必须具有相关性,并且方案必须简单易用,易于在日常工作中实施。

试验注册

该研究的方案在北爱尔兰试验方法学研究中心(SWAT ID 64)注册。EFFECTS 研究的 EudraCT 编号为 2011-006130-16,并于 2016 年 2 月 17 日在 ClinicalTrials.gov 注册,编号为 NCT02683213。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d37c/6822437/b2c33fe43ff0/13063_2019_3737_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验